ES2084722T3 - Composicion para tratamiento del ojo seco. - Google Patents

Composicion para tratamiento del ojo seco.

Info

Publication number
ES2084722T3
ES2084722T3 ES91106698T ES91106698T ES2084722T3 ES 2084722 T3 ES2084722 T3 ES 2084722T3 ES 91106698 T ES91106698 T ES 91106698T ES 91106698 T ES91106698 T ES 91106698T ES 2084722 T3 ES2084722 T3 ES 2084722T3
Authority
ES
Spain
Prior art keywords
composition
dry eye
eye treatment
eye
microliters
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91106698T
Other languages
English (en)
Inventor
Thomas Glonek
Donald R Korb
Jack V Greiner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ocular Research of Boston Inc
Original Assignee
Ocular Research of Boston Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ocular Research of Boston Inc filed Critical Ocular Research of Boston Inc
Application granted granted Critical
Publication of ES2084722T3 publication Critical patent/ES2084722T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)

Abstract

UN METODO Y COMPOSICION PARA REDUCIR LA EVAPORACION DE UNA CAPA ACUOSA DESDE LA SUPERFICIE DEL OJO. EL METODO COMPRENDE EL APLICAR UNA MEZCLA DE UN FOSFOLIPIDO CARGADO Y UN ACEITE NO POLAR SOBRE EL OJO, PREFERIBLEMENTE EN FORMA DE UN ACEITE META-ESTABLE EN EMULSION ACUOSA EN UNA DOSIS QUE NO EXCEDE LOS 100 MICROLITROS.
ES91106698T 1990-05-29 1991-04-25 Composicion para tratamiento del ojo seco. Expired - Lifetime ES2084722T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US52965790A 1990-05-29 1990-05-29
US63821591A 1991-01-07 1991-01-07

Publications (1)

Publication Number Publication Date
ES2084722T3 true ES2084722T3 (es) 1996-05-16

Family

ID=27063077

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91106698T Expired - Lifetime ES2084722T3 (es) 1990-05-29 1991-04-25 Composicion para tratamiento del ojo seco.

Country Status (12)

Country Link
US (1) US5294607A (es)
EP (1) EP0459148B1 (es)
JP (1) JP3281392B2 (es)
AT (1) ATE132366T1 (es)
AU (1) AU648304B2 (es)
CA (1) CA2043366C (es)
DE (1) DE69115990T2 (es)
ES (1) ES2084722T3 (es)
GR (1) GR3019478T3 (es)
IL (1) IL98237A (es)
RU (1) RU2092138C1 (es)
TW (1) TW200396B (es)

Families Citing this family (124)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5364632A (en) * 1989-04-05 1994-11-15 Yissum Research Development Company Of The Hebrew University Of Jerusalem Medicinal emulsions
ZA927277B (en) * 1991-10-02 1993-05-19 Boston Ocular Res Dry eye treatment process and solution.
EP0733918B1 (en) * 1995-03-24 2003-07-30 Ocular Research of Boston, Inc. Hydrogel lens pre-coated with lipid layer
DE19511322C2 (de) 1995-03-28 1999-09-02 Mann Gerhard Chem Pharm Fab Sterile Augengele mit einem Gehalt an mittelkettigen Triglyceriden und Verfahren zu deren Herstellung
US5616342A (en) * 1995-04-11 1997-04-01 Pdt, Inc. Emulsioin suitable for administering a poorly water-soluble photosensitizing compound and use thereof
DE19527132A1 (de) * 1995-07-25 1997-01-30 Laevosan Gmbh & Co Kg Ophthalmologische Ozonschutzzusammensetzung
US5696166A (en) * 1995-10-31 1997-12-09 Yanni; John M. Compositions containing hydroxyeicosatetraenoic acid derivatives and methods of use in treating dry eye disorders
JPH10218760A (ja) * 1997-02-04 1998-08-18 Nobel Igaku Kenkyusho:Kk ドライアイ治療用の微量油添加目薬
ZA989513B (en) 1997-10-21 1999-04-21 Alcon Lab Inc Compositions containing histamine H2 agonists and methods of use in treating dry eye
RU2125427C1 (ru) * 1998-05-27 1999-01-27 Миронова Эмилия Михайловна Средство для лечения глазных заболеваний - оковидит
EP0982025A1 (en) * 1998-08-28 2000-03-01 Wilhelm Prof. Dr. Stoffel Synthetic tear fluid
WO2000038690A2 (en) 1998-12-24 2000-07-06 Alcon Laboratories, Inc. Prostaglandin e agonists for treatment of dry eye
AU2183900A (en) 1998-12-24 2000-07-31 Alcon Laboratories, Inc. Ep4 receptor agonists for treatment of dry eye
DE60024594T2 (de) 1999-03-01 2006-08-17 Vista Scientific Llc, Andover Ophthalmologische zubereitung die mucin enthält
AUPQ228199A0 (en) * 1999-08-18 1999-09-09 Sly, Anthony William Ophthalmic fluid
MXPA02004699A (es) 1999-11-09 2004-09-10 Alcon Inc Derivados de acidos hidroxieicosatetraenoico modificados con cadena omega y metodos de su uso para el tratameinto del ojo reseco.
US6803385B2 (en) 1999-11-09 2004-10-12 Alcon, Inc. Hydroxyeicosatetraenoic acid analogs and methods of their use in treating dry eye disorders
AU1226001A (en) 1999-11-09 2001-06-06 Alcon Universal Limited Phospholipids of hydroxyeicosatetraenoic acid-like derivatives
US6552084B2 (en) 1999-11-09 2003-04-22 Alcon Universal Ltd. Hydroxyeicosatetraenoic acid analogs and methods of their use in treating dry eye disorders
ATE296792T1 (de) 1999-11-09 2005-06-15 Alcon Inc Benzenoidderivate von 15- hydroxyeicosatetraensäure und verfahren zur verwendung zur behandlung des trockenen auges
US6458854B2 (en) 1999-11-09 2002-10-01 Alcon Universal Ltd. Phospholipids of hydroxyeicosatetraenoic acid-like derivatives and methods of use
WO2001034550A2 (en) 1999-11-09 2001-05-17 Alcon Universal Ltd. 15-hydroxyeicosatetraenoic acid analogs with enhanced metabolic stability and methods of their use in treating dry eye disorders
PT1228027E (pt) 1999-11-09 2004-08-31 Alcon Inc Derivados de 15-hete com heteroatomo substituinte em posicao 3 e homologos com dois carbonos e metodos de utilizacao
MXPA02004703A (es) 1999-11-09 2004-09-10 Alcon Inc Composiciones que contienen derivados de acido hidroxieicostetraenoico y metodos de uso para tratar trastornos de resequedad en los ojos.
HK1045302B (en) 1999-11-09 2005-10-14 Alcon, Inc. Hydroxyeicosatetraenoate salts, compositions and methods of use in treating dry eye disorders
KR20020050238A (ko) 1999-11-09 2002-06-26 구이도 콜러, 스테판 바슬러 15-하이드록시에이코사테트라엔산-관련 화합물 및 사용 방법
DE60008143T2 (de) 1999-11-09 2004-12-30 Alcon, Inc. Lipoxin-a4 und deren analoge zur behandlung von trockenen augen
AU1101301A (en) 1999-11-09 2001-06-06 Alcon Universal Limited 2,2-difluoro 15-hydroxyeicosatetraenoic acid analogs and methods of use
DE60019322T2 (de) 1999-11-09 2005-09-08 Alcon Inc. Heteroatomunterbrochene analoge von15-hydroxyeicosatetraensäure und verfahren zu deren verwendung
WO2001046134A1 (en) 1999-12-22 2001-06-28 Alcon Universal Ltd. 6-KETO PROSTAGLANDIN F1α AND ANALOGS FOR TREATING DRY EYE
US6348508B1 (en) 2000-04-04 2002-02-19 Bausch & Lomb Incorporated Method for treating dry eye
US7524511B1 (en) 2000-07-12 2009-04-28 Rogue Valley Natural Springs, Inc. Method and kit for moisturizing the surface of the eye
ES2523101T3 (es) * 2000-07-12 2014-11-20 Rogue Valley Natural Springs, Inc. Método y kit para hidratar la superficie del ojo
US6872382B1 (en) 2001-05-21 2005-03-29 Alcon, Inc. Use of selective PDE IV inhibitors to treat dry eye disorders
CN1239161C (zh) * 2001-05-21 2006-02-01 爱尔康公司 可用于治疗干眼疾病的类固醇
US7112588B2 (en) * 2001-05-21 2006-09-26 Alcon, Inc. Use of proteasome inhibitors to treat dry eye disorders
ES2278049T3 (es) 2001-05-21 2007-08-01 Alcon, Inc. Uso de inhibidores de proteasoma para tratar trastornos de ojo seco.
BR0209965A (pt) 2001-05-21 2004-04-06 Alcon Inc Uso de inibidores de nf-kappab para tratar distúrbios do olho seco
US6645994B1 (en) 2001-06-01 2003-11-11 Alcon, Inc. Method of treating dry eye disorders
FR2827190A1 (fr) * 2001-06-22 2003-01-17 Rhodia Chimie Sa Utilisation d'une huile comprenant un groupement polaire comme aide au depot d'une huile polaire non ionisable
US6750250B1 (en) * 2001-07-12 2004-06-15 Alcon, Inc. 11,12-oxidoarachidonic acid derivatives and methods of their use in treating dry eye disorders
DE10141018A1 (de) * 2001-08-22 2003-03-13 Eth Zuerich Eidgenoessische Te Verwendung von negativ geladenen Phospholipiden, sowie Zusammensetzungen umfassend Phospholipide zur Behandlung des Auges
AR035293A1 (es) * 2001-08-23 2004-05-05 Novartis Ag Composicion oftalmica.
US20040214754A1 (en) * 2001-10-03 2004-10-28 Ellis Edward J. Ophthalmic preparation containing glycomacropeptide
US20040220089A1 (en) * 2001-10-03 2004-11-04 Ellis Edward J. Ophthalmic preparation containing glycoprotein
JP2005505592A (ja) * 2001-10-11 2005-02-24 アルコン，インコーポレイテッド 抗炎症性ステロイドとｍｕｃ−１分泌促進薬との組み合わせによる、ドライアイを処置するための方法
US20030109508A1 (en) * 2001-10-11 2003-06-12 Alcon, Inc. Methods for treating dry eye
US6656460B2 (en) * 2001-11-01 2003-12-02 Yissum Research Development Method and composition for dry eye treatment
AU782913B2 (en) * 2001-11-02 2005-09-08 Santen Sas Method and composition for dry eye treatment
AU2003243282B2 (en) * 2002-05-17 2008-05-01 Othera Holding, Inc. Amelioration of the development of cataracts and other opthalmic diseases
RU2232582C2 (ru) * 2002-07-29 2004-07-20 Уфимский научно-исследовательский институт глазных болезней Глазная пленка
JP2006502183A (ja) * 2002-09-20 2006-01-19 アルコン，インコーポレイテッド ドライアイ障害の処置のためのサイトカイン合成インヒビターの使用
US20040248794A1 (en) * 2002-12-20 2004-12-09 Yanni John M. Treatment of dry eye by restoring 15-lipoxygenase activity to ocular surface cells
WO2004093878A1 (en) 2003-04-16 2004-11-04 Alcon, Inc. Use of fused pyridazine derivatives for treating dry eye disorders
US7825134B2 (en) * 2003-05-19 2010-11-02 Othera Holding, Inc. Amelioration of cataracts, macular degeneration and other ophthalmic diseases
RU2245137C1 (ru) * 2003-06-18 2005-01-27 Государственное учреждение Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова Фармацевтическая композиция для лечения воспалительных процессов вирусной этиологии в глазном яблоке
WO2005025539A1 (ja) * 2003-09-10 2005-03-24 Senju Pharmaceutical Co., Ltd. コンタクトレンズ用眼科用組成物
MXPA03011987A (es) 2003-12-19 2005-06-23 Osio Sancho Alberto Metodo para el tratamiento de la presbicia induciendo cambios en el poder y fisiologia corneal.
CA2552524A1 (en) * 2004-01-10 2005-07-28 Biolipid, Inc. Lipid compositions and methods of use
US20050182039A1 (en) * 2004-02-13 2005-08-18 Bausch & Lomb Incorporated Use of Loteprednol etabonate for the treatment of dry eye
JP2007530573A (ja) 2004-03-25 2007-11-01 ボーシュ アンド ローム インコーポレイティド ドライアイの治療にロテプレドノールエタボネートを使用すること
ES2334368T3 (es) * 2004-05-14 2010-03-09 Alcon, Inc. Procedimiento de tratamiento de trastornos de ojo seco y uveitis.
US7923471B2 (en) * 2004-05-14 2011-04-12 Alcon, Inc. Method of treating dry eye disorders and uveitis
CA2572344A1 (en) * 2004-07-01 2006-01-19 Schepens Eye Research Compositions and methods for treating eye disorders and conditions
WO2006009112A1 (ja) * 2004-07-16 2006-01-26 Taisho Pharmaceutical Co., Ltd. 水性点眼剤
US7223737B1 (en) 2004-08-13 2007-05-29 Alcon, Inc. Method of treating dry eye disorders using glycosides
JPWO2006022291A1 (ja) * 2004-08-27 2008-05-08 千寿製薬株式会社 ドライアイ治療用点眼液
US20060128803A1 (en) * 2004-12-14 2006-06-15 Alcon, Inc. Method of treating dry eye disorders using 13(S)-HODE and its analogs
US9161905B2 (en) * 2005-01-12 2015-10-20 Ocular Research Of Boston, Inc. Dry eye treatment
AU2012201476B2 (en) * 2005-01-12 2014-07-17 Ocular Research Of Boston, Inc Dry eye treatment
TWI393567B (zh) * 2005-03-31 2013-04-21 Bausch & Lomb 治療乾眼之組合物及相關之製造方法及使用方法
TW200722109A (en) * 2005-03-31 2007-06-16 Bausch & Lomb Polysaccharide and polyol composition for treating dry eye and related methods of manufacture and methods of use
PT2471530T (pt) 2005-06-01 2017-04-19 Edison Pharmaceuticals Inc Produtos terapêuticos com atividade redox para o tratamento de doenças mitocondriais e de outras condições e modulação de biomarcadores energéticos
WO2007005421A2 (en) * 2005-07-01 2007-01-11 Bausch & Lomb Incorporated Long lasting alginate dry eye, related methods of manufacture and methods of use
WO2007058935A2 (en) * 2005-11-14 2007-05-24 Bausch & Lomb Incorporated Ophthalmic composition for dry eye therapy
JP5748385B2 (ja) * 2006-01-13 2015-07-15 大正製薬株式会社 Ｏ／ｗ型エマルション水性点眼剤
JP6033177B2 (ja) * 2006-01-13 2016-11-30 大正製薬株式会社 Ｏ／ｗ型エマルション水性点眼剤
EP1986636B1 (en) 2006-02-22 2013-04-24 Edison Pharmaceuticals, Inc. Phenol and 1,4-benzoquinone derivatives for use in the treatment of mitochondrial diseases
US7745461B1 (en) 2006-02-27 2010-06-29 Alcon Research, Ltd. Method of treating dry eye disorders
ES2284398B2 (es) 2006-04-27 2008-12-16 Universidad Complutense De Madrid Formulacion de vesiculas liposomales en soluciones acuosas con caracteristicas de pelicula lagrimal.
US7691811B2 (en) * 2006-05-25 2010-04-06 Bodor Nicholas S Transporter-enhanced corticosteroid activity and methods and compositions for treating dry eye
CN101484187B (zh) * 2006-07-07 2012-12-26 博士伦公司 包含解离的糖皮质激素受体激动剂和免疫抑制剂的用于治疗干眼症的组合物
US20080057022A1 (en) * 2006-08-30 2008-03-06 Erning Xia Ophthalmic Pharmaceutical Compositions and Uses Thereof
US8138156B2 (en) * 2006-10-18 2012-03-20 Bausch & Lomb Incorporated Ophthalmic compositions containing diglycine
US20080095754A1 (en) * 2006-10-18 2008-04-24 Burke Susan E Ophthalmic compositions comprising diglycine
WO2008052037A2 (en) * 2006-10-24 2008-05-02 Alcon Research, Ltd. Packaging materials for formulations containing 2-pyrrolidone derivatives
WO2008052031A2 (en) * 2006-10-24 2008-05-02 Alcon Research, Ltd. 2-pyrrolidone derivatives for preservation of ophthalmic, otic and nasal compositions
US20080188573A1 (en) * 2007-02-02 2008-08-07 Alcon Research, Ltd. Use of thy1-fp transgenic mouse for the identification of ophthalmic agents
WO2008120249A1 (en) * 2007-03-30 2008-10-09 Sifi S.P.A. Pharmaceutical formulations based on apolar and polar lipids for ophthalmic use
WO2008137496A1 (en) 2007-05-04 2008-11-13 Bausch & Lomb Incorporated Compositions for reducing, ameliorating, treating, or preventing condition of dry eye and methods of making and using same
US20080280853A1 (en) * 2007-05-07 2008-11-13 Erning Xia Compositions for reducing, ameliorating, treating, or preventing condition of dry eye and methods of making and using same
WO2008154129A1 (en) * 2007-06-08 2008-12-18 Bausch & Lomb Incorporated Pharmaceutical compositions and method for treating, reducing, ameliorating, alleviating, or preventing dry eye
US20090142292A1 (en) * 2007-12-03 2009-06-04 Blackwell Richard I Method For The Mitigation of Symptoms of Dry Eye
US8629099B2 (en) * 2008-03-25 2014-01-14 Bausch & Lomb Incorporated Ophthalmic compositions comprising a dipeptide
US8314153B2 (en) 2008-09-10 2012-11-20 Edison Pharmaceuticals, Inc. Treatment of pervasive developmental disorders with redox-active therapeutics
US20110195927A1 (en) * 2008-09-15 2011-08-11 Compositions Comprising Polymers Having Aminio Sugar Unites And Methods Of Making And Using Same Compositions Comprising Polymers Having Amino Sugar Units and Methods of Making and Using Same
US8539938B2 (en) * 2009-03-12 2013-09-24 Ford Global Technologies, Llc Fuel systems and methods for controlling fuel systems in a vehicle with multiple fuel tanks
PL2424495T3 (pl) 2009-04-28 2018-06-29 Bioelectron Technology Corporation Leczenie dziedzicznej neuropatii nerwów wzrokowych lebera i dominującego zaniku nerwu wzrokowego chinonami tokotrienolu
TWI478730B (zh) * 2009-12-03 2015-04-01 Alcon Res Ltd 眼科乳劑
US8658614B2 (en) 2010-08-13 2014-02-25 The University of Texas Health Science Center Aptamer-containing compositions and methods for targeting E-selectin
US9161531B2 (en) 2011-02-23 2015-10-20 Donald R. Korb High alcohol content sanitizer
US8859525B2 (en) 2011-07-19 2014-10-14 Bausch & Lomb Incorporated Pharmaceutical compositions comprising mushroom-based polysaccharides and uses thereof
WO2013043387A1 (en) 2011-09-22 2013-03-28 Bausch & Lomb Incorporated Ophthalmic gel compositions
US8324171B1 (en) 2012-02-06 2012-12-04 Bausch & Lomb Incorporated Ophthalmic compositions containing diglycine
US8664180B2 (en) 2012-02-06 2014-03-04 Bausch & Lomb Incorporated Ophthalmic compositions containing diglycine
US9278132B2 (en) 2012-02-13 2016-03-08 Bausch & Lomb Incorporated Ophthalmic pharmaceutical compositions and methods of making and using same
JP2015509495A (ja) 2012-02-24 2015-03-30 ボシュ・アンド・ロム・インコーポレイテッドＢａｕｓｃｈ ＆ Ｌｏｍｂ Ｉｎｃｏｒｐｏｒａｔｅｄ アルコキシル化天然ワックスを有する眼用組成物
JP6016465B2 (ja) * 2012-06-12 2016-10-26 ロート製薬株式会社 ビタミンａ類を含有する水性組成物
CN104823100B (zh) 2012-08-10 2020-04-24 奥西奥公司以约利亚健康公司名义经营 隐形眼镜和为个体的眼睛测定隐形眼镜的适配的方法
WO2014116787A1 (en) 2013-01-24 2014-07-31 Bausch & Lomb Incorporated Poly(nitrogen/amine) derivatives of a natural wax and ophthalmic compositions
US10302658B2 (en) 2014-03-12 2019-05-28 University Of Virginia Patent Foundation Compositions and methods for treating eye infections and disease
WO2015171516A1 (en) 2014-05-05 2015-11-12 Thetis Pharmaceuticals Llc Compositions and methods relating to ionic salts of peptides
CN107074884A (zh) 2014-06-18 2017-08-18 西蒂斯制药有限责任公司 活性剂的矿物质氨基酸复合物
ES2861502T3 (es) 2015-11-05 2021-10-06 Univ Louisville Res Found Inc Anestesia y analgesia locales y regionales
WO2017106803A1 (en) 2015-12-17 2017-06-22 Bioelectron Technology Corporation Flouroalkyl, flouroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders
JP6906047B2 (ja) 2016-06-03 2021-07-21 テティス・ファーマシューティカルズ・エルエルシー 特異的炎症収束性メディエーターの塩に関連する組成物及び方法
US9981041B2 (en) 2016-08-23 2018-05-29 Ira Jason Salzman Ophthalmic lubricating spray
US12233017B2 (en) 2016-10-14 2025-02-25 Olympic Ophthalmics, Inc. Quiet handheld devices and methods for treatment of disorders
US20180296390A1 (en) * 2017-04-18 2018-10-18 David Hoare Apparatus and method for treating a number of eye conditions of a user including dry eye syndrome and/or burns to the eyes
TWI884130B (zh) 2018-02-21 2025-05-21 瑞士商愛爾康公司 基於脂質的眼用乳劑
US11147737B2 (en) 2018-02-26 2021-10-19 Olympic Ophthalmics, Inc. Handheld device with motorized member for treatment of disorders
CA3120453A1 (en) 2018-12-10 2020-06-18 EternaTear, Inc. Ophthalmic formulations providing durable ocular lubrication
US11471475B1 (en) 2022-03-08 2022-10-18 Ralph P. Stone Ophthalmic suspension vehicles and related methods for pharmaceutical ingredient delivery
US11679078B1 (en) 2022-03-08 2023-06-20 EternaTear, Inc. Ophthalmic formulations and related methods

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4677099A (en) * 1981-09-04 1987-06-30 Yeda Research And Development Co., Ltd. Medical processes employing a novel lipid fraction
US4421748A (en) * 1982-07-13 1983-12-20 Trager Seymour F Artificial tear aid
US4839175A (en) * 1986-07-28 1989-06-13 Liposome Technology, Inc. Liposomes with enhanced retention on mucosal tissue
US4804539A (en) * 1986-07-28 1989-02-14 Liposome Technology, Inc. Ophthalmic liposomes
JPH02500360A (ja) * 1986-07-28 1990-02-08 リポソーム　テクノロジー，インコーポレイテッド 粘膜組織上での高い保持力を有するリポソーム
US4818537A (en) * 1986-10-21 1989-04-04 Liposome Technology, Inc. Liposome composition for treating dry eye
US4914088A (en) * 1987-04-02 1990-04-03 Thomas Glonek Dry eye treatment solution and method
US4866049A (en) * 1987-08-10 1989-09-12 Spectra Pharmaceutical Services, Inc. Ophthalmic compositionn and method of using same
CA2013755C (en) * 1989-04-05 1993-11-30 Simon Benita Medicinal emulsions

Also Published As

Publication number Publication date
JPH04279525A (ja) 1992-10-05
AU7619191A (en) 1992-08-06
RU2092138C1 (ru) 1997-10-10
GR3019478T3 (en) 1996-07-31
EP0459148A3 (en) 1992-10-14
CA2043366C (en) 1999-01-05
ATE132366T1 (de) 1996-01-15
DE69115990T2 (de) 1996-05-30
US5294607A (en) 1994-03-15
TW200396B (es) 1993-02-21
IL98237A0 (en) 1992-06-21
AU648304B2 (en) 1994-04-21
DE69115990D1 (de) 1996-02-15
EP0459148B1 (en) 1996-01-03
JP3281392B2 (ja) 2002-05-13
CA2043366A1 (en) 1991-11-30
IL98237A (en) 1996-08-04
EP0459148A2 (en) 1991-12-04

Similar Documents

Publication Publication Date Title
ES2084722T3 (es) Composicion para tratamiento del ojo seco.
ES2052664T3 (es) Solucion de tratamiento de "ojo seco".
DE69633399D1 (de) Verlängerte freisetzung von gm-csf
DE69320362D1 (de) Nicht-wässrige emulgierte oberflächenbehandlungszusammensetzung
DE69432228D1 (de) Fluorierte öl-in-wasser-emulsion zur oberflächenbehandlung
FR2720644B1 (fr) Emulsion eau-dans-huile sans tensioactif.
ITPT970001A0 (it) Dispositivo di assemblaggio semplificato per l'allestimento di regoli e/0 strutture che li contengono realizzati in carta, cartone e materiali similari
MX164018B (es) Metodo para tratar substratos
DE68914657D1 (de) Vorrichtung zur herstellung von eiskugeln und anwendung derselben zwecks oberflächenbehandlung.
ES509570A0 (es) Perfeccionamientos en un dispositivo de aplicacion de un liquido para el tratamiento o la distribuicion de vegetales".
PT85089A (pt) Papel para fotografia provido de uma camada impermeavel a agua constituida por uma poliolefina
NO158984C (no) Anvendelse av (e)-beta-farnesen i vaeskeform eller av en (e)-beta-farnesen-inneholdende vaeske som et kontaktinsekticidmot bladlus.
ATE50369T1 (de) Fotografischer papiertraeger und verfahren zu seiner herstellung.
DE58903937D1 (de) Vorrichtung zum abscheiden ueberschuessigen spruehmaterials beim spruehauftragen von nasslack.
ES500425A0 (es) Dispositivo para la distribucion de dos o mas sustancias en diferentes porcentajes.
ES263570Y (es) "aparato para el secado rapido de articulos de lenceria y similares".
EP0139460A3 (en) Benzodiazepines and their therapeutic use
FI950849L (fi) Menetelmä paperikoneen pintojen pintaominaisuuksien säätelyä varten ja menetelmän käyttö paperikoneen pintojen pintakäsittelyyn
ES520268A0 (es) Procedimiento para producir un conjunto compuesto con accion sanitaria o higienica, tal como en desodorante ambiental,un cuerpo perfumante o similar.
DK0653938T3 (da) Topisk middel
MX9304870A (es) Composicion de agua en aceite y metodo para teñir madera.
ES266933Y (es) "dispositivo limitador de velocidad para ascensores y similares".
ES515930A0 (es) "procedimiento para la fabricacion de paneles de recubrimiento grabados superficialmente".
ES512939A0 (es) "perfeccionamientos en los dispositivos para el ajuste de pedestales de muebles o similares".
ES512608A0 (es) "maquina napadora para la fabricacion de moquetas y similares".

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 459148

Country of ref document: ES